cepharanthine has been researched along with Colitis Gravis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
He, L; Wang, HG; Wen, X; Yang, XZ; Zhang, JL; Zhang, MH; Zhang, MN | 1 |
He, L; Wang, HG; Wang, JY; Wen, X; Xie, R; Yang, XZ; Zhang, MH; Zhang, MN | 1 |
2 other study(ies) available for cepharanthine and Colitis Gravis
Article | Year |
---|---|
Cepharanthine ameliorates dextran sulphate sodium-induced colitis through modulating gut microbiota.
Topics: Animals; Benzylisoquinolines; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S | 2022 |
Cepharanthine Alleviates DSS-Induced Ulcerative Colitis via Regulating Aconitate Decarboxylase 1 Expression and Macrophage Infiltration.
Topics: Animals; Benzylisoquinolines; Colitis; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Humans; Macrophages; Mice; Mice, Inbred C57BL | 2023 |